medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-2-128-131medsovet-1736Research ArticleУРОЛОГИЯUROLOGYГИПЕРАКТИВНЫЙ МОЧЕВОЙ ПУЗЫРЬ У ЖЕНЩИН С ПРОЛАПСОМ ГЕНИТАЛИЙ В МЕНОПАУЗЕOVERACTIVE BLADDER IN WOMEN WITH GENITAL PROLAPSE DURING MENOPAUSEИмельбаеваА. Г.ImelbayevaA. G.ЯщукА. Г.YaschukA. G.

д.м.н., профессор

MD, Prof.

МусинИ. И.MusinI. I.Башкирский государственный медицинский университет Минздрава РоссииРоссияBashkir State Medical University, Russia’s Ministry of HealthRussian Federation20173012201702128131Copyright © Имельбаева А.Г., Ящук А.Г., Мусин И.И., 20172017Имельбаева А.Г., Ящук А.Г., Мусин И.И.Imelbayeva A.G., Yaschuk A.G., Musin I.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1736

Эпидемиологические исследования показали, что синдром гиперактивного мочевого пузыря (ГМП) входит в десятку самых распространенных заболеваний, опережая сахарный диабет, язвенную болезнь желудка и двенадцатиперстной кишки. Кроме того, с каждым годом отмечается неуклонный рост числа больных ГМП. Распространенность синдрома ГМП колеблется от 12 до 22%, несмотря на значительное снижение качества жизни, лишь 4–6,2% пациентов обращаются за помощью к специалистам.

Epidemiological studies showed that overactive bladder (OAB) syndrome is among the ten most common diseases, ahead of diabetes, gastric ulcer and duodenal ulcer. In addition, the number of patients with OAB is steadily growing every year. Prevalence of OAB ranges from 12 to 22%, and despite a significant decline in the quality of life, only 4–6,2% of patients seek the help of professionals.

пролапс гениталийнедержание мочименопаузапостменопаузаГМПпессарийсолифенацина сукцинатgenital prolapseurinary incontinencemenopausepostmenopauseOACpessarysolifenacin succinateReferencesHullfish K, Fenner D, Sorser SA, Visger J, Clayton A, Steers WD. Postpartum depression, urge urinary incontinence, and overactive bladder syndrome: Is there an association? Int Urogynecol J Pelvic Floor Dysfunct, 2007, 18: 1121-1126.Hullfish K, Fenner D, Sorser SA, Visger J, Clayton A, Steers WD. Postpartum depression, urge urinary incontinence, and overactive bladder syndrome: Is there an association? Int Urogynecol J Pelvic Floor Dysfunct, 2007, 18: 1121-1126.Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn, 2010, 29(1): 4-20.Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn, 2010, 29(1): 4-20.Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: A population-based study in Finland. Am J Obstet Gynecol, 2008, 199(153): e1-12.Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: A population-based study in Finland. Am J Obstet Gynecol, 2008, 199(153): e1-12.Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial. Am J Obstet Gynecol, 2006, 195: 1730-1735.Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial. Am J Obstet Gynecol, 2006, 195: 1730-1735.Кулаков В.И., Аполихина И.А., Деев А.Д. Акушерско-гинекологические факторы риска недержания мочи у женщин. Акушерство и гинекология, 2005, 3: 32-36.Кулаков В.И., Аполихина И.А., Деев А.Д. Акушерско-гинекологические факторы риска недержания мочи у женщин. Акушерство и гинекология, 2005, 3: 32-36.Hashim H, Abrams P. Is the bladder an unreliable witness for predicting detrusor overactivity? J Urol, 2006, 175: 191-194.Hashim H, Abrams P. Is the bladder an unreliable witness for predicting detrusor overactivity? J Urol, 2006, 175: 191-194.Waetjen LE, Feng WY, Ye J, Johnson WO, Greendale GA, Sampselle CM, Sternfield B, Harlow SD, Gold EB. Factors associated with worsening and improving urinary incontinence across the menopausal transition. Obstetrics and Gynecology, 2008, 111: 667-677.Waetjen LE, Feng WY, Ye J, Johnson WO, Greendale GA, Sampselle CM, Sternfield B, Harlow SD, Gold EB. Factors associated with worsening and improving urinary incontinence across the menopausal transition. Obstetrics and Gynecology, 2008, 111: 667-677.Краснопольский В.И., Буянова С.Н., Петрова В.Д. Диагностика типов недер жание мочи у женщин при пролапсе гениталий. Вестник, 1999, 3: 53-56.Краснопольский В.И., Буянова С.Н., Петрова В.Д. Диагностика типов недер жание мочи у женщин при пролапсе гениталий. Вестник, 1999, 3: 53-56.Oelke V, Khullar H. Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials. World J Urol, 2013, 31: 1093-1094.Oelke V, Khullar H. Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials. World J Urol, 2013, 31: 1093-1094.

The authors declare that there are no conflicts of interest present.